Knoll Capital Management as of June 30, 2019
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 22 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Hldgs | 28.3 | $35M | 5.0M | 6.93 | |
| Biohaven Pharmaceutical Holding | 26.9 | $33M | 750k | 43.79 | |
| Abeona Therapeutics | 9.2 | $11M | 2.4M | 4.78 | |
| Blackstone Group Com Unit Ltd | 5.6 | $6.8M | 153k | 44.42 | |
| Krystal Biotech (KRYS) | 4.8 | $5.9M | 147k | 40.27 | |
| Altria (MO) | 3.5 | $4.3M | 90k | 47.36 | |
| Applied Therapeutics (APLT) | 3.2 | $3.8M | 467k | 8.24 | |
| Eiger Biopharmaceuticals | 3.0 | $3.7M | 350k | 10.60 | |
| Aldeyra Therapeutics (ALDX) | 2.6 | $3.2M | 529k | 6.00 | |
| Kraneshares TR Bosera Msci Ch (KBA) | 2.4 | $3.0M | 96k | 30.96 | |
| Anavex Life Sciences Corp Com New (AVXL) | 2.0 | $2.4M | 724k | 3.37 | |
| Dupont De Nemours (DD) | 1.8 | $2.3M | 30k | 75.07 | |
| Galmed Pharmaceuticals SHS | 1.2 | $1.5M | 206k | 7.35 | |
| Dow (DOW) | 1.2 | $1.5M | 30k | 49.30 | |
| Entera Bio SHS (ENTX) | 1.2 | $1.5M | 476k | 3.10 | |
| Molecular Templates | 0.8 | $951k | 114k | 8.35 | |
| Corteva (CTVA) | 0.7 | $887k | 30k | 29.57 | |
| Electrocore | 0.7 | $794k | 397k | 2.00 | |
| Soligenix | 0.5 | $595k | 838k | 0.71 | |
| Catasys Com Par | 0.2 | $281k | 15k | 19.23 | |
| Lipocine | 0.1 | $97k | 50k | 1.94 | |
| Vascular Biogenics | 0.0 | $28k | 21k | 1.31 |
